Trials / Completed
CompletedNCT03993366
Pramlintide and Fiasp Closed-Loop With a Simple Meal Announcement
A Preliminary Pilot Study to Assess Insulin-plus-Pramlintide Closed-loop Delivery System in Pump Treated Patients With Type 1 Diabetes Mellitus
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- McGill University · Academic / Other
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this pilot study is to generate preliminary data of (i) Fiasp-plus-Pramlintide closed-loop system with a simple meal announcement, compared to (ii) Fiasp-alone closed-loop system with full carbohydrate counting, in preparation for an outpatient study over two weeks
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | Fiasp+Pramlintide Closed-Loop System | Closed-loop insulin delivery with Fiasp insulin and pramlintide |
| DEVICE | Fiasp Closed-Loop System | Closed-loop insulin delivery with Fiasp insulin alone |
Timeline
- Start date
- 2019-03-01
- Primary completion
- 2019-08-06
- Completion
- 2019-08-06
- First posted
- 2019-06-20
- Last updated
- 2021-04-01
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT03993366. Inclusion in this directory is not an endorsement.